January 30, 2019
Prospective Observational Analysis Of CR With Sunitinib Treatment In mRCC Patients
Read More
January 30, 2019
Prospective Observational Analysis Of CR With Sunitinib Treatment In mRCC Patients
Read More
January 30, 2019
Sutent Rechallenge In mRCC Patients
Read More
January 30, 2019
Study Of The Impact Of Inlyta In 2nd Line On The Treatment Outcomes Of mRCC Patients Treated With Sutent In 1st Line In The Real Life Setting
Read More
January 30, 2019
The Study of ALN-TTR02 (Patisiran) for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Who Have Already Been Treated With ALN-TTR02 (Patisiran)
Read More
January 30, 2019
The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Who Have Already Been Treated With ALN-TTR02 (Patisiran)
Read More
January 30, 2019
Safety and Tolerability of Patisiran (ALN-TTR02) in Transthyretin (TTR) Amyloidosis
Read More
January 30, 2019
Treatment for Endogenous Cushing’s Syndrome
Read More
January 30, 2019
A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Lower Risk Myelodysplastic Syndrome (MDS) Without Del 5q
Read More
December 10, 2018
Phase IV-Cervical Dystonia-INTEREST IN CD2
Read More
December 10, 2018
APOLLO: The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis
Read More
X